BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+8.83%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.57T
AUM Growth
+$193B
(+5.7%)
Cap. Flow
-$58.9B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
18.35%
Holding
5,584
New
300
Increased
1,993
Reduced
2,724
Closed
121
Top Buys
| 1 |
Palantir
PLTR
|
+$1.05B |
| 2 |
Sea Limited
SE
|
+$771M |
| 3 |
Blackstone
BX
|
+$713M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$698M |
| 5 |
Wells Fargo
WFC
|
+$697M |
Top Sells
| 1 |
Alibaba
BABA
|
+$16.8B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$5.54B |
| 3 |
Apple
AAPL
|
+$3.6B |
| 4 |
Microsoft
MSFT
|
+$3.52B |
| 5 |
Linde
LIN
|
+$2.05B |
Sector Composition
| 1 | Technology | 22.69% |
| 2 | Healthcare | 13.59% |
| 3 | Financials | 13.13% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPTK.U
3301
DELISTED
Crown PropTech Acquisitions Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CPTK.U
| $17.9M | ﹤0.01% |
1,800,000
| – | – |
|
|
ITI
3302
DELISTED
Iteris, Inc.
ITI
| $17.8M | ﹤0.01% |
2,678,600
-242,752
| -8% | -$1.61M |
|
3303
Alta Equipment Group
ALTG
$239M
| $17.8M | ﹤0.01% |
1,337,743
+119,207
| +10% | +$1.58M |
|
3304
South Plains Financial
SPFI
$646M
| $17.8M | ﹤0.01% |
768,674
-11,248
| -1% | -$260K |
|
|
AZUL
3305
DELISTED
Azul
AZUL
| $17.8M | ﹤0.01% |
673,026
+106,342
| +19% | +$2.81M |
|
3306
Arbutus Biopharma
ABUS
$855M
| $17.7M | ﹤0.01% |
5,835,573
+3,737,863
| +178% | +$11.3M |
|
3307
4D Molecular Therapeutics
FDMT
$318M
| $17.6M | ﹤0.01% |
731,410
+184,006
| +34% | +$4.43M |
|
|
SQZ
3308
DELISTED
SQZ Biotechnologies Company
SQZ
| $17.6M | ﹤0.01% |
1,215,951
+983,747
| +424% | +$14.2M |
|
3309
Nokia
NOK
$24.3B
| $17.5M | ﹤0.01% |
3,294,745
+859,553
| +35% | +$4.57M |
|
3310
Home Bancorp
HBCP
$433M
| $17.5M | ﹤0.01% |
458,729
-13,444
| -3% | -$512K |
|
|
ONIT
3311
Onity Group Inc.
ONIT
$367M
| $17.4M | ﹤0.01% |
560,593
+403,267
| +256% | +$12.5M |
|
|
VTNR
3312
DELISTED
Vertex Energy, Inc
VTNR
| $17.4M | ﹤0.01% |
1,312,514
+1,297,015
| +8,368% | +$17.2M |
|
3313
Stagwell
STGW
$1.35B
| $17.3M | ﹤0.01% |
2,962,701
+2,773,433
| +1,465% | +$16.2M |
|
3314
Intercorp Financial Services
IFS
$4.68B
| $17.3M | ﹤0.01% |
689,868
+65,168
| +10% | +$1.64M |
|
|
BRT
3315
BRT Apartments
BRT
$290M
| $17.2M | ﹤0.01% |
994,166
-65,958
| -6% | -$1.14M |
|
3316
iShares Core Conservative Allocation ETF
AOK
$639M
| $17.2M | ﹤0.01% |
433,101
-6,372
| -1% | -$254K |
|
3317
Biomea Fusion
BMEA
$115M
| $17.2M | ﹤0.01% |
+1,101,689
| New | +$17.2M |
|
|
CHNGU
3318
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| $17.2M | ﹤0.01% |
225,614
-29,252
| -11% | -$2.22M |
|
3319
Peoples Financial Services
PFIS
$525M
| $17.1M | ﹤0.01% |
402,013
-30,179
| -7% | -$1.29M |
|
3320
CorMedix
CRMD
$966M
| $17.1M | ﹤0.01% |
2,493,014
+239,720
| +11% | +$1.64M |
|
3321
Main Street Capital
MAIN
$5.99B
| $17.1M | ﹤0.01% |
416,141
+38,344
| +10% | +$1.58M |
|
3322
XP
XP
$9.94B
| $17.1M | ﹤0.01% |
392,436
+292,832
| +294% | +$12.8M |
|
3323
Agnico Eagle Mines
AEM
$77B
| $17M | ﹤0.01% |
281,431
-16,494
| -6% | -$997K |
|
|
ESTE
3324
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $17M | ﹤0.01% |
1,534,750
+38,987
| +3% | +$432K |
|
3325
Oramed Pharmaceuticals
ORMP
$98.8M
| $17M | ﹤0.01% |
1,269,530
+1,190,970
| +1,516% | +$15.9M |
|